lagen-I, and fibronectin as myofibroblastic markers [mouse monoclonal anti-human ␣-SMA and rabbit polyclonal anti-human collagen-␣1 type 1/collagen-I, Santa Cruz Biotechnology; mouse monoclonal anti-human fibronectin, Abcam, Cambridge, UK]; Nox4 as a specific renal isoform of NADPH oxidase enzyme (rabbit polyclonal anti-human Nox4, Abcam); and ␤-actin as a housekeeping gene (mouse monoclonal anti-human ␤-actin, clone AC-15, Sigma-Aldrich, St. Louis, MO).
Tissue immunofluorescence and confocal laser-scanning microscopy. Paraffin-embedded sections (3-4 m) of apparently normal tissue fragments from kidneys removed for RCC, pre-and posttransplant graft biopsies of recipients with DGF were used. The protein expression of BMP-2, CD133, ␣-SMA, NOX4, CD24, Pax-2, ALK-2, ALK-3, and ALK-6 was evaluated by indirect immunofluorescence and confocal microscopy analysis. Antigen unmasking was performed by boiling the slices in citrate buffer for 15 min. Sections were permeabilized in PBS with 0.05% Tween 20 for 5 min, washed in PBS, and then blocked with 2% BSA in PBS for 1 h at room temperature. Sections were incubated overnight in a humidified chamber at 4°C with a primary antibody against BMP-2 (1:50), CD133 (1:5), ␣-SMA (1:100), NOX4 (1:200), CD24 (1:50), and Pax-2 (1:200), following incubation for 1 h with the appropriate secondary antibody (Alexa Fluor 488 rabbit anti-goat, 1:400, Alexa Fluor 555 goat anti-mouse, 1:200, and Alexa Fluor 633 goat anti-mouse, 1:400, Molecular Probes, Eugene, OR; biotinylated anti-rabbit IgG and Texas red streptavidin, Vector Laboratories, Burlingame, CA). The sections were counterstained with To-pro-3 or Sytox (Molecular Probes), mounted in GEL/MOUNT (Biomeda, Foster City, CA), and sealed with nail varnish. Negative controls were performed by omitting the primary antibodies. Specific fluorescence was acquired by a Leica TCS SP2 (Leica, Wetzlar, Germany) confocal laser-scanning microscope using an ϫ63 objective lens. Two independent observers (A. Loverre and F. Rascio) blinded to the origin of the slides counted the number of tubular BMP-2 ϩ CD133 ϩ cells in at least 15 consecutive high-power (ϫ630) fields (0.0567-mm 2 high-power field/section) for each sample. The values were then averaged. The final reported count was the mean of the two observer measures. In no case was the interobserver variability greater than 20%.
ARPC isolation. ARPCs were isolated by magnetic sorting from normal tissue fragments of kidneys removed for RCC, as reported elsewhere (4, 18) . Briefly, samples were fragmented, filtered, and the tubular fraction was cultured in EGM-MV medium (Lonza, Valais, Switzerland) supplemented with 20% FBS (Sigma-Aldrich) for 1 wk. Cells were detached by trypsin/EDTA digestion and washed with ice-cold MACS buffer (PBS pH 7.2 with 0.5% BSA and 2 mM EDTA). Cells were passed through a 30-m filter, counted, and incubated in MACS buffer with the same volume (10 5 cells/l) of FcR blocking reagent and anti-CD133 antibody-conjugated magnetic microbeads (Miltenyi Biotec). Cells were passed through an MS column (Miltenyi Biotec) under a magnetic field generated by a Mini MACS Separation Unit (Miltenyi Biotec). CD133 ϩ cells retained inside the column were washed, eluted, and resuspended in EGM-MV with 20% FBS.
Other cell cultures. Immortalized proximal tubular epithelial cells (HK2) were purchased from the American Type Culture Collection (ATCC, Rockville, MD) and grown in DMEM-F12 medium (SigmaAldrich) with the supplementation of 1% antibiotics and 10% FBS (Sigma-Aldrich).
For in vitro experiments. ARPCs were plated, grown to confluence, serum-starved, and stimulated with 200 M H 2O2 (Sigma-Aldrich) for the indicated time points. ARPCs and HK2 cells were plated and stimulated with 30 ng/ml recombinant human BMP-2 (Sigma-Aldrich) for the indicated time points. When preincubation with N-acetylcysteine (NAC; Sigma-Aldrich) or diphenyleneiodonium chloride (DPI; Sigma-Aldrich) was required, cells were stimulated with 5 mM NAC or 10 M DPI for 1 h and then BMP-2 was added in the same medium.
Small interfering RNA transfection. Small interfering (si) RNA was purchased from Qiagen (Valencia, CA). A nonsilencing siRNA sequence, tagged with Alexa Fluor 488 (AllStars Negative Control siRNA; Qiagen), was used to determine uptake transfection efficiency. For in vitro delivery, siRNA (25 nM) was incubated with 5 l TransIT-TKO Transfection Reagent (Mirus) for 20 min at room temperature and added to cells in culture at 80% confluence in 12-well plates. All procedures were performed according to the manufacturer's instructions. Silencing was confirmed by real-time PCR. Functional effects were observed when inhibition of Nox4 expression was ϳ40% and higher.
RNA extraction and gene expression analysis. ARPCs were lysed with the appropriate lysis buffer, and RNA was extracted according to the manufacturer's instructions (Charge Switch RNA Extraction Kit, Invitrogen, Carlsbad, CA). Total RNA was quantified by measuring the absorbance at 260 nm with a spectrophotometer (NanoDrop Technologies Wilmington, DE) and reverse transcribed (Applied Biosystems, Foster City, CA). Two microliters of cDNA were amplified by semiquantitative PCR using primers specific for the ACVR-2 gene (5=-ACCAAATCTTCCCCTTGCTT-3= forward; 5=-CCTCCTC-GGAAGACACTCTG-3= reverse, Invitrogen), ALK-2 gene (5=-ACA-CAGCCCACTTCAAATCC-3= forward; 5=-ACCAAATCTTCCCC-TTGCTT-3= reverse, Invitrogen), ALK-3 gene (5=-TTTATGGCAC-CCAAGGAAAG-3= forward; 5=-TGGTATTCAAGGGCACATCA-3= reverse, Invitrogen), and ALK-6 gene (5=-AAATGTGGGCACCAA-GAAAG-3= forward; 5=-ACAGGCAACCCAGAGTCATC-3= reverse, Invitrogen). Amplified sequences were loaded in an agarose gel stained with ethidium bromide, and fluorescence intensity was measured using ELISA analysis. Collected supernatants were used for a commercially available BMP-2 ELISA assay (Quantikine, R&D Systems, Minneapolis, MN). The assay was performed according to the manufacturer's instructions. Optical density was determined using a microplate reader set to 450 nm.
Cell immunofluorescence and confocal laser-scanning microscopy. The expression of ␣-SMA was evaluated by indirect immunofluorescence and confocal microscopy analysis of ARPCs stimulated with 30 ng/ml BMP-2 for 5 days and fixed in 4% paraformaldehyde. Cells were blocked for 1 h (2% BSA in PBS, pH 7.4), incubated with the primary antibody, and then with a secondary antibody (Alexa Fluor 488 goat anti-mouse IgG1, 1:200, Molecular Probes). The cells were counterstained with To-pro-3 (Molecular Probes). Negative controls were obtained by incubating cells with the blocking solution and then omitting the primary antibody or using a nonspecific IgG control. Specific fluorescence was acquired using an ϫ63 objective lens.
Immunoblotting. Cells were lysed with RIPA buffer (1 mM PMSF, 5 mM EDTA, 1 mM sodium orthovanadate, 150 mM sodium chloride, 8 g/ml leupeptin, 1.5% Nonidet P-40, 20 mM Tris·HCl, pH 7.4). The lysates were centrifuged at 10,000 g at 4°C for 10 min. Protein concentration was determined by the Bradford method (Bio-Rad Laboratories). Proteins were subjected to SDS-PAGE on a 7.5 or a 10% gel (for ␣-SMA) and then electrotransferred onto polyvinylidene difluoride membranes (Millipore, Bedford, MA). The filter was blocked for with 5% nonfat milk powder in PBS containing 0.1% Tween 20 (TBS). The blot was then incubated with antibodies directed toward ALK-2, ALK-3, ALK-6 (1:200), ␣-SMA (1:500), collagen-I (1:100), fibronectin (1: 1,000), or Nox4 (1:100). The membranes were washed in TBS and incubated with horseradish peroxidase-conjugated antibodies (mouse anti-goat IgG 1:15,000, goat anti-rabbit IgG 1:10,000, Santa Cruz Biotechnology; goat anti-mouse IgG 1:50,000, Bio-Rad Laboratories). Membranes were stripped, immunoblotted with anti-␤-actin antibody (1: 10,000 in TBS), and the signal was detected using the enhanced chemiluminescence system (Amersham, Piscataway, NJ). The film was acquired using a scanner (EPSON Perfection 2580 Photo) and quantified by NIH ImageJ software. ␤-Actin band intensity was used for equal loading control and for normalization.
Measurement of intracellular reactive oxygen species production. The oxidation-sensitive fluorescent probe 2=,7=-dichlorodihydrofluorescein diacetate (DCF-DA; Molecular Probes) was used to detect the generation of intracellular reactive oxygen species (ROS) as described previously (8) . This compound is converted by intracellular esterases to DCF, which is then oxidized by hydrogen peroxide to the highly fluorescent DCF. ARPCs were stimulated with BMP-2 (30 ng/ml) for the indicated time points. Cells were washed with HBSS without phenol red and detached by trypsin/EDTA digestion. After two . Two microliters of cDNA were amplified by semiquantitative PCR using primers specific for the ACVR-2, ALK-2, ALK-3, ALK-6 genes. ␤-Actin gene expression was used for normalization (A). Cells were lysed, total proteins were collected, and 40 g of total proteins were used for immunoblotting against ALK-2, ALK-3, and ALK-6. All tested cell lines express the three BMP type I receptors (B). We analyzed the expression of BMP receptors (ALK2, ALK3, and ALK6) before (pre-DGF) and after injury (DGF) by immunofluorescence. We observed CD133/BMP receptor colocalization in DGF.
washes with HBSS, cells were incubated with 10 M DCF-DA for 30 min in the dark at 37°C. DCF fluorescence was detected at excitation of 495-nm and emission of 525-nm wavelengths, with a fluorescence reader (JASCO-FP-6200, Tokyo, Japan). Emitted fluorescence was normalized to the total amount of proteins.
NAD(P)H oxidase assay. NAD(P)H oxidase activity was determined by the lucigenin-enhanced chemiluminescence method as described previously (9, 29) . ARPCs were stimulated with BMP-2 (30 ng/ml) for the indicated time periods, then rinsed in PBS, scraped in lysis buffer (20 mM KH 2PO4, pH 7.0, 1 mM EGTA, 1 mM PMSF, 8 g/ml leupeptin) on ice and centrifuged at (800 g) at 4°C for 10 min. To start the assay, 100 l of supernatants were added to 900 l of 50 mM phosphate buffer, pH 7.0, containing 1 mM EGTA, 150 mM sucrose, 5 M lucigenin, and 100 M NADPH (Roche Diagnostic, Mannheim, Germany). Photon emission in terms of relative light units was measured every 30 s for 6 min in a luminometer. A buffer blank was subtracted from each reading. Superoxide production was expressed as the rate of relative chemiluminescence (light) units per minute per microgram of protein (RLU·min Ϫ1 ·g Ϫ1 ). Protein content was measured using the Bradford method (Bio-Rad Laboratories).
Statistical analysis. Data are expressed as means Ϯ SD. Differences between groups were analyzed by unpaired t-test analysis or ANOVA, as appropriate. A P value Ͻ0.05 was considered statistically significant. Statistical analysis was performed using the Statview Software package (version 5.0; SAS, Cary, NC).
RESULTS

BMP-2 is expressed in the normal human adult kidney.
To detect the basal expression of BMP-2 protein in the adult human kidney, we performed immunofluorescence on paraffin-embedded sections from normal portions of kidneys. We focused our attention at the cortical area, where most BMP-2ϩ cells were localized within tubular sections and in the glomeruli (Fig. 1, A and B) . We observed the presence of BMP-2ϩ cells at the glomerular level within the parietal layer of Bowman's capsule (Fig. 1B) . The BMP-2 expression pattern was widespread but not ubiquitous.
ARPCs express BMP-2 in vivo. To verify whether CD133ϩ cells express BMP-2, we performed double-staining immunofluorescence using adult human kidney sections. All BMP-2-expressing cells presented a specific fluorescence for CD133, at both the tubular and glomerular level (Fig. 1B) . Additionally, we demonstrated, by triple immunofluorescence, BMP-2 production in cells coexpressing CD133, CD24, and Pax-2 markers (Fig. 1, C and D) .
Acute kidney injury increases BMP-2 expression in vivo. Comparing BMP-2 and CD133 coexpression in pre-and posttransplant biopsies of the same kidneys in renal transplant recipients undergoing DGF, we observed a striking significant increase in BMP-2 protein in ARPCs after acute injury (pre-DGF 9.99 Ϯ 4.51 BMP- (Fig. 2, A-D) . ARPCs and HK2 tubular cells express BMPR. We analyzed the presence of type I BMP receptors (BMPRI), ALK-2, ALK-3, and ALK-6, and of type II BMP receptor (BMPRII) ACVR-2 in both ARPCs and on tubular HK2 cell lines. PCR and immunoblotting experiments demonstrated that these cells expressed BMPR (Fig. 3, A and B) , suggesting a potential responsiveness of these cells to BMP-2 action. In transplanted kidneys with DGF, we observed an increase in ALK2, ALK3, and ALK-6 expression (Fig. 3C) , compared with the same kidneys before acute injury. The BMPR colocalized with CD133, a marker of renal progenitor cells, suggesting the presence of these receptors in ARPCs during DGF.
BMP-2 induces a myofibroblastic transition in ARPCs but not in tubular cells. To study the biological effects of BMP-2 on ARPCs and on HK2 cells, we stimulated cultured cells with BMP-2 (30 ng/ml) for 5 days. By immunofluorescence (Fig. 4A) and immunoblotting (Fig. 4B) , we showed a significant increase in the myofibroblastic marker ␣-SMA following BMP-2 stimulation in ARPCs (basal 0.28 Ϯ 0.11 AU vs. BMP-2 0.78 Ϯ 0.2 AU, P ϭ 0.02) (Fig. 4D ). This effect of the growth factor was not observed in HK2 cells (basal 0.35 Ϯ 0.06 AU vs. BMP-2 0.33 Ϯ 0.09 AU) (Fig. 4, C and E) . To confirm the differentiation toward a myofibroblast-like phenotype induced by BMP-2 in ARPCs, we tested the expression of collagen I ( (Fig. 5D) protein expression in ARPCs. On the contrary, BMP-2 did not induce a significant increase in collagen I and fibronectin in HK2 cells (Fig. 5, A-D) , further suggesting that a BMP-2-driven myofibroblastic phenotype is a specific effect sorted on ARPCs.
Acute kidney injury increases ␣-SMA expression in ARPCs in vivo. In transplanted kidneys with DGF, we observed a marked increase in ␣-SMA expression (Fig. 6, D-F ) compared with the same kidneys before acute injury (Fig. 6, A-C) . The ␣-SMA colocalization with CD133, a marker of renal progenitor cells, suggested that the myofibroblastic transition of ARPCs, observed in vitro, seems to occur also in vivo, after an acute injury. The signal is specifically observed in irregular and spindle-shaped CD133ϩ cells, consistent with a transdifferentiation process. (Fig. 7A) , P ϭ 0.03 and P ϭ 0.03, respectively) (Fig. 7B) .
BMP-2 induces ROS production and NADPH oxidase activity in
BMP-2 induces Nox4 expression in ARPCs.
Immunoblot analysis showed a detectable expression of Nox4, the renal isoform of NADPH oxidase, in ARPCs cultured under normal growth conditions. Nox4 protein expression was rapidly upregulated by BMP-2, peaking after 5 min of incubation (basal (Fig. 7, C and D) . Moreover, we analyzed the BMP-2, CD133, and Nox4 protein expression in pre-and post-DGF by triple immunofluorescence. Figure 7E showed that Nox4 was localized in BMP-2-expressing CD133ϩ cells at the tubular level only after acute kidney injury. This is consistent with our in vitro results, suggesting that acute injury could enhance Nox4 expression in ARPCs, by BMP-2 induction.
ROS are required for BMP-2-induced myofibroblastic transition in ARPCs.
Since in some cell lines ␣-SMA production is ROS dependent, we investigated ␣-SMA expression by ARPCs following an oxidative stimulus. For this purpose, ARPCs were stimulated with 200 M H 2 O 2 for 48 h. Immunoblot experiments showed that H 2 O 2 significantly induced ␣-SMA protein expression (basal 1.01 Ϯ 0.20 vs. H 2 O 2 2.6 Ϯ 0.82 AU, P ϭ 0.03) (Fig. 8, A and C) . Preincubation with NAC abolished BMP-2-induced ␣-SMA upregulation (basal 1.00 Ϯ 0.58 vs. BMP-2 2.19 Ϯ 0.58 AU, P ϭ 0.03, BMP-2 vs. BMP-2ϩNAC 1.28 Ϯ 0.41 AU, P ϭ 0.04) (Fig. 8, B and D) , confirming that ROS mediate ␣-SMA induction by BMP-2.
Nox4 silencing abrogates BMP-2-induced NADPH oxidase activity and myofibroblastic transition in ARPCs in vitro.
To clarify the role of Nox4 in mediating BMP-2 action, we performed Nox4 RNA interference in ARPCs. Silencing Nox4 with a specific siRNA for 48 h resulted in a 49% reduction in gene expression level, measured by real-time PCR analyses (untransfected 1.36 Ϯ 0.35 vs. Nox4 siRNA 0.67 Ϯ 0.13 RU, P ϭ 0.03) (Fig. 9A) , and in a 39% protein reduction (untransfected 0.56 Ϯ 0.08 vs. Nox4 siRNA 0.21 Ϯ 0.03 AU, P ϭ 0.03) (Fig. 9B) . We then evaluated NADPH oxidase activation in response to BMP-2, either in silenced cells or not. Nox4 silencing resulted in a lack of activation in response to BMP-2 stimulation, evidencing that Nox4 is the main NADPH oxidase isoform involved in this process (basal 86.9 Ϯ 54.0 vs. BMP-2 15 min 185.9 Ϯ 45.8 RLU·min , P ϭ 0.005) (Fig. 9C) . To evaluate whether Nox4 silencing also resulted in a long-time functional effect, we stimulated ARPCs with BMP-2 for 5 days and analyzed ␣-SMA protein expression. Again, Nox4 RNA interference resulted in a significant reduction of ␣-SMA expression following BMP-2 stimulation, confirming that Nox4 mediates BMP-2-induced myofibroblastic differentiation of ARPCs (basal 0.36 Ϯ 0.18 vs. BMP-2 0.77 Ϯ 0.13 AU, P ϭ 0.01 and BMP-2 vs. BMP-2 siRNA 0.037 Ϯ 0.19 AU, P ϭ 0.02) (Fig. 9D) .
DISCUSSION
In the present study, we demonstrate for the first time that ARPCs express BMP-2. This growth factor may act in an autocrine fashion in these cells to induce their commitment toward a myofibroblast-like phenotype, through Nox4 (NA-DPH oxidase renal isoform)-dependent ROS production.
BMPs are secreted growth factors belonging to the large TGF-␤ superfamily and regulate a variety of biological processes, both in embryonic and adult tissues. BMPs contribute to the establishment of morphogenetic gradients during embryogenesis and promote the differentiation of mesodermderived tissues; they are involved in cell proliferation, differentiation, apoptosis, and migration, depending on the cell contexts and microenvironments (5, 24, 26, 32) . BMPs are expressed in the early developing kidney (5, 20) and in the adult kidney, particularly during repair processes, since it is known that regenerative processes recapitulate embryonal development (3, 7, 25) . Indeed, a member of the BMP family, BMP-7, is well known to be involved in repair mechanisms in the injured kidney, by antagonizing the profibrotic effects of TGF-␤ (30), by reducing proinflammatory cytokines and chemokines release (10) , and by inducing mesenchymal-toepithelial transition (MET) in adult renal fibroblasts (31) . On the contrary, little is currently known about the role of BMP-2 in this context. We observed that BMP-2 is widely expressed at both the tubular and glomerular level in the normal adult human kidney. The expression pattern is not ubiquitous, suggesting a form of regulation or a restricted phenotype-specific expression.
BMP-2 is particularly involved in stem cell biology, especially in mesoderm germ layer-derived tissues (6, 26, 32) . BMP-2 has been shown to direct, in vitro, embryonic stem cell differentiation into a cartilage, osteoblast, or adipogenic lineage, depending on supplemented cofactors (33) . Recently, several reports demonstrated that the kidney hosts ARPCs, capable of regeneration in response to injury (4, 18, 19) . We hypothesized that ARPCs could express the morphogenetic protein BMP-2 and, indeed, we observed that BMP-2 is mainly expressed in tubular and glomerular CD133 ϩ
CD24
ϩ Pax-2 ϩ cells, resident ARPCs, as demonstrated by Sallustio et al. (19) , suggesting that these cells are the main source of BMP-2 in the human adult kidney. DGF, defined as the requirement for dialysis in the first week after transplantation, is a common clinical complication after kidney transplantation, caused by acute kidney injury and characterized by a significant inflammatory activation with the involvement of many cellular and soluble mediators (13) . Several evidences suggest that DGF may significantly influence the long-term outcome of kidney transplantation (13) . We observed a dramatic increase in BMP-2 in ARPCs following renal DGF.
Since in recent studies BMP-2 expression has been shown to be regulated by a feedback loop mechanism (14) , to assess the potential responsiveness of ARPCs to BMP-2, we investigated the expression of its receptors. The BMPR is a heterodimeric complex constituted by BMPRII and BMPRI. There are three isoforms of each subunit, and their different combination likely provide different binding and signaling specificity of BMPs (28) . Following ligand-receptor complex formation, BMPRII phosphorylates BMPRI, which in turn activates downstream signaling. A pivotal role is played by BMPRI, since it is needed for the initiation of the signaling cascade and the definition of signaling specificity (28) . For this purpose, we tested the expression of the three isoforms of BMPRI (ALK-2, ALK-3, and ALK-6) and BMPRII (ACVR-2) on ARPCs and HK2. We found that both ARPCs and HK2 express all the isoforms of BMPRI and BMPRII, arguing that these cell lines are potentially responsive to BMP-2, which may act on ARPCs in an autocrine fashion, as previously shown in cardiac progenitor cells (14) .
In several recent studies, BMP-2 was shown to be sufficient or necessary to induce the epithelial-to-mesenchymal transition (EMT) ( 12, 16, 20, 22) . We then investigated whether BMP-2 could be able to induce a myofibroblastic differentiation in our model. Indeed, we observed a significant induction of ␣-SMA, a specific myofibroblastic marker, clearly indicating a differentiation toward a myofibroblast-like phenotype. BMP-2-induced collagen I and fibronectin expression further confirms this hypothesis. This effect seems to be highly specific for ARPCs, since BMP-2 was unable to induce the same phenotype in cultured proximal tubular epithelial cells. Interestingly, in graft biopsies of transplant recipients with DGF, an in vivo model of acute kidney injury, we observed a marked increase in ␣-SMA expression in CD133ϩ cells, confirming that the myofibroblastic transition of ARPCs, observed in vitro, seems to occur also in vivo.
TGB-␤ is a strong profibrotic mediator in kidney disease, being responsible for EMT in epithelial tubular cells (23, 27) . Rhyu et al. (15) showed that TGB-␤-driven EMT in proximal tubular cells requires ROS generation. It has recently been demonstrated that, in rat kidney fibroblasts, TGF-␤ induces the conversion of fibroblasts to myofibroblasts through ROS generated by NADPH oxidase enzyme activation (2) . The same authors suggest that Nox4, a NADPH oxidase renal isoform, is primarily involved in TGF-␤-induced kidney myofibroblast Fig. 9 . Nox4 silencing abrogates BMP-2-induced NADPH activity and myofibroblastic induction. ARPCs were silenced with Qiagen Nox4_5 siRNA (25 nM) for 48 h and then lysed for RNA or protein extraction. One microgram of total RNA was retrotranscribed and amplified by real-time PCR with SyberGreen for the Nox4 gene. GADPH gene expression was used for normalization. *P ϭ 0.03 vs. untransfected; n ϭ 3 (A). Forty micrograms of total proteins were used for immunoblotting against Nox4. *P ϭ 0.03 vs. untransfected; n ϭ 3 (B). Transfected and untransfected ARPCs were treated with BMP-2 (30 ng/ml) for 15 min, and NADPH oxidase activity was measured by lucigenin-enhanced chemiluminescence. *P ϭ 0.04 vs. basal. **P ϭ 0.005 vs. BMP-2 15 min; n ϭ 4 (C). Transfected and untransfected ARPCs were treated with BMP-2 (30 ng/ml) for 5 days, and ␣-SMA protein expression was analyzed by immunoblotting. *P ϭ 0.01 vs. basal. **P ϭ 0.02 vs. BMP-2; n ϭ 4 (D). activation through ROS generation (2) . Following BMP-2 stimulation in ARPCs, we showed a rapid increase in intracellular ROS production along with a marked enhancement in NADPH oxidase activity. Interestingly, in our system the differentiation toward a myofibroblast-like phenotype is also dependent upon ROS generation. Indeed, the ROS scavenger NAC inhibits BMP-2-induced ␣-SMA upregulation. In addition, we demonstrated that ARPCs express Nox4, and this expression was rapidly upregulated by BMP-2, with a peak after 5 min of stimulation. Interestingly, the upregulation in Nox4 protein expression temporally anticipates ROS production, supporting the involvement of Nox4 in this process. Nox4 silencing confirmed this hypothesis, since, following BMP-2 stimulation, it resulted in a lack of NADPH oxidase activation and of myofibroblastic transformation of ARPCs in response to BMP-2. To confirm and validate our in vitro observations, we studied the expression and localization of Nox4 in kidney biopsies of transplant recipients experiencing DGF. The evidence of colocalization of Nox4 with BMP-2 in CD133ϩ cells further supports our hypothesis that during acute kidney injury BMP-2 may induce Nox4 expression. Recently, it has been shown that progenitor cells are potentially responsive to a regulation system, in which BMP-2 mediates a fine negative feedback loop, balancing differentiation and proliferation through opposing effects on cell induction or proliferation (13, 14) . Moreover, BMP-2 is part of a complex balance system together with BMP-7 and other BMPs (21) .
In summary, our data provide the first evidence that 1) ARPCs express BMP-2; 2) this expression is significantly upregulated in an acute kidney injury human model in vivo; 3) BMP-2 may induce the commitment of ARPCs toward a myofibroblastic phenotype; and 4) this profibrotic effect is mediated by the activation of Nox4. Overall, our data suggest that BMP-2, expressed by ARPCs, may modulate the balance between the quiescent state, proliferation, the EMT process, and ARPC differentiation toward a myofibroblastic-like phenotype and shed light on a novel molecular mechanism linking acute kidney injury with progressive renal damage. This mechanism may be regulated by a feedback loop system, whose imbalance may lead, in some kind of injuries, to renal fibrosis. Further studies are required to clarify the role of ARPCs in the pathogenesis of renal fibrosis, hopefully leading to pharmacological strategies aimed to enhance the regenerative properties and to block the profibrotic pathways.
